Tuesday, June 30, 201572
Doctors and scientists continue to find the keys to new cancer treatments that unlock the body's own immune system.
The attorneys at Wallace and Graham in Salisbury, N.C. continue to follow the advances in Immunotherapy treatment for cancer. This is cutting edge research that continues to make great leaps forward in helping people battle against cancers, such as mesothelioma, lung cancer and asbestosis and to help their clients improve and hopefully extend their quality of life. In May 2015, during a researchers meeting in Chicago, researchers began to hail what they believe is a potent new weapon in the fight against cancer: the body's own immune system. An international study recently found that a combination of two drugs that helped allow the immune system to fight the cancer -- ipilimumab and nivolumab -- stopped the deadly skin cancer melanoma from advancing for nearly a year in almost 60 % of the cases. As reported to CNN, melanoma, though a skin cancer, can spread to the lungs, liver, bone, lymph nodes and brain resulting in incurable cancer. Not only should people, especially those who work outside or are otherwise exposed to the sun, get regular checkups but if something unusual is noted on their skin they should immediately get it looked at. The sooner it is noticed the better the chances are of stopping or controlling the spread of the cancer. This recent study plus other studies Wallace & Graham has noted in prior articles, show great promise in treating lung cancer. While those involved in the fight against cancer are divided as to just how excited to get over the promise of immunotherapy in battling cancer, they all strive to find a cure and to help their patients and those who will unfortunately, become patients Many of the researchers describe the results as 'encouraging,' and 'promising' "Immunotherapy drugs have already revolutionized melanoma treatment, and now we're seeing how they might be even more powerful when they're combined," said Dr. Steven O'Day, an expert with the American Society of Clinical Oncology. "But the results also warrant caution -- the nivolumab and ipilimumab combination used in this study came with greater side effects, which might offset its benefits for some patients. Physicians and patients will need to weigh these considerations carefully," O'Day told CNN. In the study, 36% of the patients receiving the two-drug combination had to stop the therapy due to side effects. Both drugs are made by Bristol-Myers Squibb, the sponsors of the study. The side effects are holding back some treatments so traditional curative measures, burning the cancer off or taking surgical steps to remove it are still the predominate modality for treating skin cancer. Nell Barrie, a spokeswoman for Cancer Research UK, indicated that much remains to be learned and the new drugs, at this time, would not replace any of the existing cancer treatments. Surgery, Dr. Barrie said, would remain vital. So, too, would chemotherapy and radiotherapy, She noted that researchers had yet to study the long-term survival rates for immunotherapy. The side effects, which stopped 36% of the patients to discontinue the therapy, can include inflammation of the stomach and bowel serious enough to require hospitalization, she said. Other Doctors are more optimistic and forward thinking about immunotherapy which, while advancing rapidly, in the scheme of life, is really still in its infancy. For example, Dr. James Larkin, the lead author of the melanoma study, called the results a game changer. Wallace & Graham continues to monitor the development of Immunotherapy with great interest as the firm has a long history of not only advocating for the victims of corporate cancers, such as mesothelioma, asbestosis and lung cancer but also takes pride in staying abreast of the current treatment options. This allows the firm to try and keep its clients fully informed so they can ask and can rely upon their physicians to discuss all the treatment options. Wallace & Graham always recommends, above all else, that cancer victims listen to and rely upon their doctors, like those at Duke Medical Center, who are well versed in the latest cancer treatment options and rely upon the experienced lawyers at Wallace & Graham for explanations of their legal rights. For a free no obligation confidential consultation or meeting please just call 1-800-849-5291. Wallace & Graham attorneys can meet with you at the office or at your home to discuss your legal options. Source: The research was presented in Chicago at the annual conference of the American Society of Clinical Oncology and published in The New England Journal of Medicine. CNN Article Dated June 1 by Don Melvin CNN reporter.